Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
about
Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAF Mutant Melanoma That Cannot Be Removed by Surgery
description
clinical trial
@en
klinisch onderzoek
@nl
name
Dabrafenib and Trametinib in T ...... t Cannot Be Removed by Surgery
@en
type
label
Dabrafenib and Trametinib in T ...... t Cannot Be Removed by Surgery
@en
prefLabel
Dabrafenib and Trametinib in T ...... t Cannot Be Removed by Surgery
@en
P6153
P1050
P1476
A Randomized Phase II Trial of ...... n BRAF V600E/K Mutant Melanoma
@en
P3098
NCT02196181
P4844
P580
2014-07-22T00:00:00Z
P582
2020-06-15T00:00:00Z